Page 6,789«..1020..6,7886,7896,7906,791..6,8006,810..»

Diplomat Specialty Pharmacy Names Industry Veteran, Gary Kadlec, new Company President

Posted: Published on June 11th, 2012

FLINT, Mich, June 11, 2012 /PRNewswire/--Diplomat Specialty Pharmacy, the nation's largest, privately owned specialty pharmacy, announced today that pharmacy executive, Gary W. Kadlec, has joined the company and will be serving as President. Gary will report to Diplomat Specialty Pharmacy's CEO, Philip Hagerman. "Gary is an experienced industry leader with a true passion for patient care and for the pharmacy profession," said Hagerman. "His unique experience as both a business entrepreneur and seasoned Pharmacy executive will be a tremendous asset as we work together to continue Diplomat's industry-leading growth." As President, Kadlec will support and drive the Sales, Clinical, Managed Care, New Business and Operations teams at Diplomat Specialty Pharmacy. "It is obvious to me that Diplomat Specialty Pharmacy's commitment to the proper care of each and every patient is a key factor in the success of the company," said Kadlec. "My father and grandfather, both pharmacists, were also committed to their patients and I've modeled my entire career after both of them. I am excited to be joining such a fine company and staff that share the same vision of the role of pharmacy in patient care as we grow Diplomat together." Prior to joining Diplomat, Kadlec was the … Continue reading

Posted in Pharmacy | Comments Off on Diplomat Specialty Pharmacy Names Industry Veteran, Gary Kadlec, new Company President

U.S. News & World Report and Pharmacy Times to Name Top Health Product Recommendations

Posted: Published on June 11th, 2012

NEW YORK--(BUSINESS WIRE)-- U.S. News & World Report, the nations leading publisher of quality rankings, and Pharmacy Times, the pharmacy industrys leading publication, have announced a new collaboration that will identify the top pharmacist-recommended over-the-counter (OTC) products for consumers. For the past 16 years, Pharmacy Times has researched and compiled pharmacists insights and preferences in its annual companion publication, titled OTC Guide. Prior to the U.S. News & World Report alliance, this yearly supplement to Pharmacy Times had been a resource provided solely to professionals in the health care industry. Thanks to this new collaboration, however, consumers nationwide soon will have insight into pharmacists go-to brands in more than 150 categories, from head (migraine, allergy relief and cough/cold) to toe (joint pain and foot cream). In gathering OTC data, Pharmacy Times conducted a proprietary annual survey that reaches a significant portion of the publications 170,000 pharmacist readers to collect feedback about 14 distinct therapeutic health areas comprising 162 product categories. This research results in the evaluation and ranking of more than 1,000 OTC products. One of U.S. News signature franchises is its Best" series of guides in key consumer decision areas such as colleges, graduate schools, mutual funds, cars, travel … Continue reading

Posted in Pharmacy | Comments Off on U.S. News & World Report and Pharmacy Times to Name Top Health Product Recommendations

Doctor: Commerce Secretary's seizure could be early sign of epilepsy

Posted: Published on June 11th, 2012

The nations eyes have turned to the story of U.S. Commerce Secretary John Bryson, who has been charged with striking two different cars multiple times with his Lexus, within the time span of a couple of minutes, in Southern California this past Saturday afternoon. After hitting the first vehicle, Los Angeles law enforcement said Bryson proceeded to get out of his car to speak with the other cars occupants. But as he was leaving the scene, Bryson allegedly hit their car yet again and then hit a second vehicle a few minutes later. Bryson was later found unconscious in his car and was admitted to a hospital where he was treated for "non-life threatening injuries." According to police, there was no evidence that alcohol or drugs were involved in the incident. A spokesperson for the Commerce Department revealed in a statement Monday that Bryson had apparently suffered a seizure while driving this weekend. The official also said that Bryson has since been released and was given medication for the seizure. While it was not clear whether or not Brysons episode caused the accidents, one expert believes that its entirely possible that a seizure could be responsible and that Bryson may … Continue reading

Comments Off on Doctor: Commerce Secretary's seizure could be early sign of epilepsy

Three Pediatric Epilepsy Fellowship Grants for Major Hospitals Announced at Annual Care and Cure Benefit in Beverly …

Posted: Published on June 11th, 2012

Los Angeles, CA (PRWEB) June 11, 2012 At its signature annual Care and Cure Benefit in Beverly Hills on Tuesday, June 5, the Epilepsy Foundation of Greater Los Angeles announced three new Pediatric Epilepsy Fellowship grants for three major hospitals in the region. With too few neurologists to treat the numbers of children with epilepsy, its a serious uphill battle for patients and their families. And even if a patient can be seen by a specialist, these clinically complex cases must be approached on a case by case basis, said Andrew Gumpert, one of co-chairs of the Benefit and a Trustee of the Epilepsy Foundation of Greater Los Angeles. To address the need for more epilepsy specialists, the Care and Cure Benefit to End Epilepsy in Children raises funds to support the training of doctors at Mattel Childrens Hospital at the University of California, Los Angeles, USC-County Medical Center, Childrens Hospital Los Angeles and the University of California, San Francisco. The doctors chosen to receive these grants will focus their attention on providing clinical care and research that will profoundly benefit children with epilepsy who lack access to quality treatment for their seizures. To date, the Care and Cure Benefit … Continue reading

Comments Off on Three Pediatric Epilepsy Fellowship Grants for Major Hospitals Announced at Annual Care and Cure Benefit in Beverly …

Freezer failure at brain bank hampers autism research

Posted: Published on June 11th, 2012

A freezer malfunction at Harvard-affiliated McLean Hospital has severely damaged one-third of the worlds largest collection of autism brain samples, potentially setting back research on the disorder by years, scientists say. An official at the renowned brain bank in Belmont discovered that the freezer had shut down in late May, without triggering two alarms. Inside, they found 150 thawed brains that had turned dark from decay; about a third of them were part of a collection of autism brains. This was a priceless collection, said Dr. Francine Benes, director of the Harvard Brain Tissue Resource Center, where the brains were housed. You cant express its value in dollar amounts, said Benes, who is leading one of two internal investigations into the freezer failure. The damage to these brains could slow autism research by a decade as the collection is restored, said Carlos Pardo, a neuropathologist and associate professor of neurology at Johns Hopkins University. The collection, owned by the advocacy and research organization Autism Speaks, yields very, very important information that allows us to have a better understanding of what autism is, as well as the contribution of environmental and immune factors, said Pardo, whose 2004 study of brains stored … Continue reading

Comments Off on Freezer failure at brain bank hampers autism research

Top risk of stroke for normal-weight adults: Getting under 6 hours of sleep

Posted: Published on June 11th, 2012

ScienceDaily (June 11, 2012) Habitually sleeping less than six hours a night significantly increases the risk of stroke symptoms among middle-age to older adults who are of normal weight and at low risk for obstructive sleep apnea (OSA), according to a study of 5,666 people followed for up to three years. The participants had no history of stroke, transient ischemic attack, stroke symptoms or high risk for OSA at the start of the study, being presented June 11 at SLEEP 2012. Researchers from the University of Alabama at Birmingham recorded the first stroke symptoms, along with demographic information, stroke risk factors, depression symptoms and various health behaviors. After adjusting for body-mass index (BMI), they found a strong association with daily sleep periods of less than six hours and a greater incidence of stroke symptoms for middle-age to older adults, even beyond other risk factors. The study found no association between short sleep periods and stroke symptoms among overweight and obese participants. "In employed middle-aged to older adults, relatively free of major risk factors for stroke such as obesity and sleep-disordered breathing, short sleep duration may exact its own negative influence on stroke development," said lead author Megan Ruiter, PhD. "We … Continue reading

Comments Off on Top risk of stroke for normal-weight adults: Getting under 6 hours of sleep

Sleep Debt Hikes Risk of Stroke Symptoms Despite Healthy BMI

Posted: Published on June 11th, 2012

Newswise Getting a good nights rest continues to be of utmost importance to your health. New data from researchers at the University of Alabama at Birmingham shows not getting enough sleep can increase the risk for stroke symptoms in people with a healthy body mass index who are at low risk for obstructive sleep apnea and have no history of stroke. The study, being presented June 11, 2012 at the SLEEP 2012 conference in Boston, looked at self-reported sleep data from 5,666 people ages 45 and older who were followed up to a three-year period. In people with a low risk for obstructive sleep apnea and a BMI of 18.5 to 24.99, which is considered optimal, there was a four-time greater risk of stroke symptoms in participants who had fewer than six hours of sleep per night, compared to participants in the same BMI range who got seven to eight hours of sleep per night. The study found no association between short sleep periods and stroke symptoms among overweight and obese participants. We adjusted for many possible factors that could explain this increase, including hypertension, high cholesterol, sleep disordered breathing and being overweight or obese, explains Megan Ruiter, Ph.D., the … Continue reading

Comments Off on Sleep Debt Hikes Risk of Stroke Symptoms Despite Healthy BMI

InVivo Therapeutics to Present at Sidoti's Semi-Annual New York Micro-Cap Conference

Posted: Published on June 11th, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced thatFrank Reynolds, InVivos Chief Executive Officer, is scheduled to make a presentation at theSidoti Semi-Annual New York Micro-Cap Conferenceat 8:00-8:35 AM EDT on Thursday, June 14, 2012, in the Estate 4 Carnegie Hall room. The Company's executives will also meet with financial community members to discussthe Company's ongoing operations. The conference will be held at the Grand Hyatt New York Hotel in midtown Manhattan. About Sidoti & Company, LLC Sidoti & Company, LLC, founded in 1999, continues to set the Wall Street standard for independent small-cap equity research, while rapidly becoming a driving force in micro-cap research, launching coverage of more than 100 equities of $200 million market cap or less since inception in mid-2010. Its analysts mine dozens of industries to provide unbiased, institutional-quality research focusing on the investment merits of profitable companies at a sub-$3 billion market cap, and it anticipates extending coverage to 700 small-cap equities by the end of 2012. About InVivo Therapeutics InVivo Therapeutics Holdings Corp. is focused on utilizing polymers as a platform technology to develop treatments to improve function … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on InVivo Therapeutics to Present at Sidoti's Semi-Annual New York Micro-Cap Conference

New Stroke Treatment Could Prevent and Reduce Brain Damage

Posted: Published on June 11th, 2012

Newswise Researchers at the University of Missouri have demonstrated the effectiveness of a potential new therapy for stroke patients in an article published in the journal Molecular Neurodegeneration. Created to target a specific enzyme known to affect important brain functions, the new compound being studied at MU is designed to stop the spread of brain bleeds and protect brain cells from further damage in the crucial hours after a stroke. Stroke is a leading cause of death in the U.S. with more than 800,000 deaths occurring each year from stroke and other cardiac events. Other than surgery, existing emergency treatments for stroke victims such as the use of a tissue plasminogen activator (tPA) must be administered within hours of the stroke onset because of the risk for brain hemorrhaging. The injectable medication can only be used to treat the most common type of stroke that occurs when blood clots block blood flow to the brain, called ischemic stroke. "For a stroke victim, time is a matter of life and death. While we are still in the research phase for this type of compound, we believe it could be combined with tPA in the future to buy ischemic stroke patients a … Continue reading

Posted in Brain Injury Treatment | Comments Off on New Stroke Treatment Could Prevent and Reduce Brain Damage

Novartis Says MS Drug Gilenya Shows Long-term Efficacy, Safety In Extended Study

Posted: Published on June 11th, 2012

(RTTNews.com) - Swiss drugmaker Novartis AG (NVS) on Monday said a new data for multiple sclerosis drug Gilenya (fingolimod) showed long-term efficacy benefit and a consistent safety profile. Gilenya, licensed from Japan'sMitsubishi Tanabe Pharma Corp., is the only oral therapy approved to treat people with relapsing forms of multiple sclerosis. The data from single-arm extension of phase III head-to-head TRANSFORMS study showed sustained reduction in relapses and rate of brain volume loss in patients on continuous Gilenya treatment for up to 4.5 years, the company noted The results also showed improved efficacy for patients switched to Gilenya from Avonex (interferon-beta-1a IM), a commonly prescribed MS treatment from Biogen Idec Inc. (BIIB). Novartis noted that reductions in relapses and MRI measures were observed in these patients. In the core TRANSFORMS study, Gilenya demonstrated superior efficacy to Avonex, reducing the annualized relapse rate by 52% at one year. The extension study showed that this low relapse rate was sustained in patients receiving continuous treatment with Gilenya for up to 4.5 years. As per the study results, patients treated with Gilenya continuously maintained a low brain atrophy rate throughout the study as measured by assessing brain volume loss, which is valued as a … Continue reading

Posted in MS Treatment | Comments Off on Novartis Says MS Drug Gilenya Shows Long-term Efficacy, Safety In Extended Study

Page 6,789«..1020..6,7886,7896,7906,791..6,8006,810..»